Article
SMAD4 mutations and cross-talk between TGF-β/IFNγ signaling accelerate rates of DNA damage and cellular senescence, resulting in a segmental progeroid syndrome-the Myhre syndrome.
GeroScience - 1 Jun 2021
Kandhaya-Pillai Renuka, Hou Deyin, Zhang Jiaming, Yang Xiaomeng, Compoginis Goli, Mori Takayasu, Tchkonia Tamara, Martin George M, Hisama Fuki M, Kirkland James L, Oshima Junko
Abstract excerpt
SMAD4 encodes a member of the SMAD family of proteins involved in the TGF-β signaling pathway. Potentially heritable, autosomal dominant, gain-of-function heterozygous variants of SMAD4 cause a rare developmental disorder, the Myhre syndrome, which is associated with a wide range of developmental and post-developmental phenotypes that we now characterize as a novel segmental progeroid syndrome. Whole-exome...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
